natural glp-1 agonist for weight loss receptor agonists Natural GLP-1s: Fact vs. Hype

Originally developed for treatment of Type 2 diabetes (T2D), many patients reported appetite and weight reductions, and utilization soon skyrocketed for people with and without T2D

BPC-157 hat eine kuerzere Halbwertszeit (circa 4 Stunden) und wird vorwiegend in der Magen-Darm- und Sehnenforschung eingesetzt

This resulted in high levels of bacterial endotoxins, sending several patients to the hospital with serious reactions (FDA safety notice)

4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells

, Panminerva Med

Enhanced ASGR2 by microplastic exposure leads to resistance to therapy in gastric cancer